<code id='452063CDE6'></code><style id='452063CDE6'></style>
    • <acronym id='452063CDE6'></acronym>
      <center id='452063CDE6'><center id='452063CDE6'><tfoot id='452063CDE6'></tfoot></center><abbr id='452063CDE6'><dir id='452063CDE6'><tfoot id='452063CDE6'></tfoot><noframes id='452063CDE6'>

    • <optgroup id='452063CDE6'><strike id='452063CDE6'><sup id='452063CDE6'></sup></strike><code id='452063CDE6'></code></optgroup>
        1. <b id='452063CDE6'><label id='452063CDE6'><select id='452063CDE6'><dt id='452063CDE6'><span id='452063CDE6'></span></dt></select></label></b><u id='452063CDE6'></u>
          <i id='452063CDE6'><strike id='452063CDE6'><tt id='452063CDE6'><pre id='452063CDE6'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:36664
          Adobe

          The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying coverage, and to speed up the pre-approval process in general.

          The new rule applies to health insurance companies that offer Medicare, Medicaid, Children’s Health Insurance Program, and Obamacare plans. It concerns so-called prior authorization requests, and will require insurers to return urgent requests within 72 hours and non-urgent requests within seven days.

          advertisement

          The changes are a win for patients seeking care, but also for health care providers like hospitals and physicians. Executives from California-based Sutter Health, Massachusetts General Brigham, and others repeatedly cited the rise in insurer denials since the pandemic at last week’s J.P. Morgan Healthcare conference.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Why liver experts renamed NASH to MASH, and NAFLD to MASLD
          Why liver experts renamed NASH to MASH, and NAFLD to MASLD

          AdobeAslateofliverdiseasesgotarebrandthisyear.Expertshopethechangecangeneratemoreconversation—andres

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

          FogPharmaCEOMathaiMammenVenrockSANFRANCISCO—SixmonthsintohistenureasCEOofcancerstartupFogPharma,Math